The latest AngioNew ECP systems from Living Data Technology Corp. incorporate technologies and know-how gained from the development and production of ECP devices for over 20 years, and represent the state of the art of sequential external counterpulsation. They are approved by the US FDA for treating angina pectoris, acute myocardial infarction, cardiogenic shock and congestive heart failure (CHF). They are also CE Mark certified for marketing in all EU countries.

AngioNew V	AngioNew VI

AngioNew-V is a mobile system, compact and light for easy storage. It does not require a dedicated treatment table - simply wheel it to the location convenient for the patient and/or doctor and treat the patient on any type of bed. AngioNew-VI, on the other hand, is built as a bed with touch screen controls. The one-piece constriction provides a quiet and space saving solution for ECP treatment centers. Both machines are fully automated - including adaptive signal adjustment and automatic inflation/deflation timing - to provide the most effective and consistent treatment with minimum operator intervention.

Please click for the combined brochure for both models.